PatentBrief

How to Make Many Copies of a Specific DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a fundamental process for making millions of copies of a specific DNA or RNA segment from a tiny sample, enabling its detection.

Granted 1987activeExpired 2006Owned by Cetus CorpInvented by Kary B. Mullis, Henry A. Erlich, Norman Arnheim + 3 more

Original patent title: “Process for amplifying, detecting, and/or-cloning nucleic acid sequences

What this patent covers

The actual claim

This patent describes a process for detecting a specific nucleic acid sequence by repeatedly copying it. First, a sample containing nucleic acids is treated with two short DNA pieces called oligonucleotide primers, one for each strand of the target sequence, under conditions where they attach and an enzyme builds new complementary strands (Claim 1a). Next, the sample is heated to separate these newly formed strands from their templates (Claim 1b). The primers and enzyme then build new strands again using the separated strands as templates (Claim 1c). Repeating these steps (Claim 2) exponentially increases the amount of the specific nucleic acid. Finally, a labeled probe is added to bind to the amplified sequence, allowing its detection (Claim 1d, 1e). For example, this process could be used to find a specific viral DNA sequence in a patient sample.

What this patent does NOT cover

The boundaries

  • Does not cover methods that amplify DNA without using two oligonucleotide primers, one for each strand of the target sequence.
  • Does not cover methods that amplify DNA without repeating the denaturation and extension steps at least once.
  • Does not cover methods for detecting a nucleic acid sequence that do not involve adding a labeled oligonucleotide probe and determining its hybridization.
  • Does not cover amplification processes where the primers do not create extension products that can themselves serve as templates for the other primer.
  • Does not cover methods that use enzymes not listed or functionally equivalent to those described in Claim 15 for polymerization.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

What made this novel

The truly novel aspect was the idea of using a pair of primers and repeated cycles of denaturation, annealing, and extension to exponentially amplify a specific DNA segment, with each newly synthesized strand serving as a template for subsequent rounds.

Process for amplifying, detect…(Primary claim)biotechpharmaceuticaldiagnosticstelecommunicationsresearch tools

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

COVID-19 diagnostic tests

02

Forensic DNA analysis (e.g., crime scene investigation)

03

Paternity testing

04

Genetic disease screening (e.g., for sickle cell anemia as mentioned in Claim 12)

05

Detection of pathogenic organisms (e.g., bacteria, viruses)

06

Gene sequencing preparation

Why it matters

The bigger picture

This patent covers the Polymerase Chain Reaction (PCR), a technique that revolutionized molecular biology, medicine, and forensics. It made it possible to study tiny amounts of DNA, leading to breakthroughs in genetic research, disease diagnosis, and criminal investigations. PCR became an indispensable tool across countless scientific and commercial applications.

Filed

February 7, 1986

Granted

July 28, 1987

Market context

Who's building on this

Companies in this space

Companies like Thermo Fisher Scientific, Bio-Rad Laboratories, and Roche Diagnostics are major players in developing and selling PCR instruments, reagents, and kits. Illumina, a leader in DNA sequencing, also relies on PCR for sample preparation. Many startups and research institutions continue to innovate new applications and variations of PCR for diagnostics and research.

Market impact

The introduction of PCR created an entirely new market for molecular diagnostic tools and reagents. It enabled the rapid and sensitive detection of pathogens, genetic mutations, and individual genetic profiles, transforming fields from medicine to forensics. The patent led to significant licensing revenues for Cetus Corp and later Hoffmann-La Roche, and its expiration opened the door for even broader adoption and innovation in the technology.

Claim 1 — Plain English

What this patent covers

This patent describes a process for detecting a specific nucleic acid sequence by repeatedly copying it. First, a sample containing nucleic acids is treated with two short DNA pieces called oligonucleotide primers, one for each strand of the target sequence, under conditions where they attach and an enzyme builds new complementary strands (Claim 1a). Next, the sample is heated to separate these newly formed strands from their templates (Claim 1b). The primers and enzyme then build new strands again using the separated strands as templates (Claim 1c). Repeating these steps (Claim 2) exponentially increases the amount of the specific nucleic acid. Finally, a labeled probe is added to bind to the amplified sequence, allowing its detection (Claim 1d, 1e). For example, this process could be used to find a specific viral DNA sequence in a patient sample.

The clever bit

The truly novel aspect was the idea of using a pair of primers and repeated cycles of denaturation, annealing, and extension to exponentially amplify a specific DNA segment, with each newly synthesized strand serving as a template for subsequent rounds.

What it does not cover

  • Does not cover methods that amplify DNA without using two oligonucleotide primers, one for each strand of the target sequence.
  • Does not cover methods that amplify DNA without repeating the denaturation and extension steps at least once.
  • Does not cover methods for detecting a nucleic acid sequence that do not involve adding a labeled oligonucleotide probe and determining its hybridization.
  • Does not cover amplification processes where the primers do not create extension products that can themselves serve as templates for the other primer.
  • Does not cover methods that use enzymes not listed or functionally equivalent to those described in Claim 15 for polymerization.

Patent Journey

From filing to expiry

Patent Filed

1986

Patent Granted

1987 · 1yr after filing

Highly Cited

6,227 patents cite this

Patent Expired

2006

PatentBrief Score

Impact Score

60/ 100

Strong

Citation count

40/40

Highly cited

Claim breadth

20/20

Very broad protection

Recency

0/20

Older than 20 years

Assignee scale

0/20

Independent or smaller assignee

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

The original legal language

Original claims

30 claims as filed with the patent office.

Citations

Patent lineage

Cites earlier patents

1

earlier patents this invention cites as foundations

View prior art →

Cited by later patents

6,227

later patents that build on this invention

View patents →

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 12564871 · 2026

A Fixture for Cleaning Showerheads with Multiple Separate Chambers

This patent describes a cleaning device for showerheads that uses a fixture with three or more separate internal compartments and channels to direct cleaning fluid to the showerhead's upper surfaces.

ASM IP HOLDING BV

US 12324579 · 2025

Surgical Stapler Battery Health Check During Operation

This patent describes a powered surgical stapler that can detect if some of its rechargeable battery cells are damaged while it's actually firing staples, helping ensure the procedure finishes safely.

CILAG GMBH INT

US 12471982 · 2025

Surgical Tool That Combines Energy Treatment and Stapling

CILAG's patent details a surgical instrument that applies therapeutic energy to tissue, monitors its properties, then deploys staples, adapting the stapling based on the initial energy treatment and monitoring.

CILAG GMBH INT

US 11918209 · 2024

Real-Time Surgical Instrument Status on Live Video During Operations

This patent describes a surgical system that shows live video from inside the body and overlays important information about the surgical tool directly onto the screen, helping surgeons operate more precisely.

CILAG GMBH INT

US 8697359 · 2014

How to Use CRISPR-Cas9 to Edit Genes in Human Cells

This patent describes a method and system for precisely altering gene expression in eukaryotic cells, including human cells, using an engineered CRISPR-Cas9 system that targets and cleaves specific DNA sequences.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Worked

Apple's 2010 patent on unlocking a device by dragging a specific graphical image along a predefined path on a touchscreen, a gesture iconic with early iPhones.

Apple Inc

Semantically similar

You might also find these interesting

SEARCH ALL

US 4237224 · 1980 · Leland Stanford Junior University

How to Make Hybrid DNA and Grow It in Microbes

US 8697359 · 2014 · Massachusetts Institute of Technology

How to Use CRISPR-Cas9 to Edit Genes in Human Cells

US 4405829 · 1983 · Massachusetts Institute of Technology

How RSA Public-Key Encryption Secures Digital Messages

US 3789832 · 1974

MRI — The Imaging Machine That Detects Cancer Without Radiation

Patent monitoring

Get notified when Cetus Corp files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: May 27, 2026 · PatentBrief is not a law firm and this is not legal advice.